100 Participants Needed

Exercise Training Program for Multiple Sclerosis

(TEAAMS Trial)

EF
Robert Motl, Ph.D profile photo
Overseen ByRobert Motl, Ph.D
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Illinois at Chicago
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores a new exercise program designed to help African-Americans with multiple sclerosis (MS) improve walking, symptoms, and overall quality of life. It compares a home-based exercise routine, known as the Guidelines for Exercise in Multiple Sclerosis (GEMS), with the FLEX Stretching and Toning Program to determine which is more effective over four months. African-Americans diagnosed with MS, living in rural areas, and struggling to maintain an exercise routine may find this trial suitable. Participants will use the internet to follow and report on their exercise activities. As an unphased trial, this study provides a unique opportunity to contribute to research that could enhance exercise programs for individuals with MS.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that this exercise training program is safe for individuals with multiple sclerosis?

Research shows that exercise is safe for people with multiple sclerosis (MS). Studies have found no increased risk of relapses or serious side effects compared to other activities. Exercise programs, such as the Guidelines for Exercise in Multiple Sclerosis (GEMS), recommend 30 minutes of aerobic exercise twice a week, along with strength training. People with MS generally tolerate these activities well, and they may improve health in various ways. Therefore, this treatment appears safe for those considering joining a trial.12345

Why are researchers excited about this trial?

Researchers are excited about the Guidelines for Exercise in Multiple Sclerosis (GEMS) because it introduces a structured, home-based exercise program specifically tailored for individuals with MS, unlike typical pharmacological treatments like interferons or glatiramer acetate. This program emphasizes aerobic and resistance exercise, which may improve physical fitness and overall quality of life for people with MS without the side effects associated with medications. The GEMS approach is unique because it provides remote support and guidance, making it accessible and convenient for participants to integrate into their daily lives. By focusing on exercise as a core component, this method may offer a complementary alternative to traditional MS treatments, potentially enhancing mobility and function.

What evidence suggests that this exercise program is effective for improving walking dysfunction in multiple sclerosis?

Research shows that exercise can help people with Multiple Sclerosis (MS). Studies have found that regular aerobic and strength training can improve walking, lift mood, and boost overall health. In this trial, participants will follow different exercise programs. The Guidelines for Exercise in Multiple Sclerosis (GEMS) is one such program, recommending at least 30 minutes of moderate aerobic exercise twice a week, along with strength exercises, to help manage MS symptoms. Evidence also suggests that exercise can benefit brain function and immune health in people with MS. Overall, exercise programs like GEMS may improve the quality of life for those with MS.23567

Who Is on the Research Team?

Motl, Robert | College of Applied ...

Robert Motl, Ph.D

Principal Investigator

University of Illinois at Chicago

Are You a Good Fit for This Trial?

This trial is for African-American adults with Multiple Sclerosis living in rural areas, who are not very active physically, can use the internet and email, speak English, have been relapse-free for 30 days, and have mild to moderate walking difficulties. It's not for those at high risk of injury or death from intense exercise.

Inclusion Criteria

I am willing to fill out the study questionnaires.
I have been diagnosed with multiple sclerosis (MS).
Insufficient physical activity (not meeting current physical activity guidelines based on GLTEQ)
See 6 more

Exclusion Criteria

Individuals with moderate to high risk for contraindications of possible injury or death when undertaking strenuous or maximal exercise (PARQ)
Individuals not meeting above inclusion criteria

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive a 4-month home-based, remotely supported exercise or stretching program

16 weeks
Remote support throughout the program

Follow-up

Participants are monitored for sustained improvements in walking dysfunction, symptoms, and HRQOL

16 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • FLEX Stretching and Toning Program
  • Guidelines for Exercise in Multiple Sclerosis (GEMS)
Trial Overview The study tests a remote exercise program tailored for African-Americans with MS against a control group doing stretching exercises. The goal is to see if the program improves walking ability, symptoms, and quality of life immediately and over four months.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Guidelines for Exercise in Multiple Sclerosis (GEMS)Experimental Treatment1 Intervention
Group II: FLEX Stretching and Toning ProgramPlacebo Group1 Intervention

Guidelines for Exercise in Multiple Sclerosis (GEMS) is already approved in United States for the following indications:

🇺🇸
Approved in United States as GEMS Exercise Program for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Illinois at Chicago

Lead Sponsor

Trials
653
Recruited
1,574,000+

University of Alabama at Birmingham

Collaborator

Trials
1,677
Recruited
2,458,000+

Bristol-Myers Squibb

Industry Sponsor

Trials
2,731
Recruited
4,127,000+
Headquarters
New York City, USA
Known For
Oncology & Cardiovascular
Top Products
Eliquis, Opdivo, Revlimid, Orencia
Christopher Boerner profile image

Christopher Boerner

Bristol-Myers Squibb

Chief Executive Officer since 2023

PhD in Business Administration from the Haas School of Business, University of California, Berkeley; BA in Economics and History from Washington University in St. Louis

Deepak L. Bhatt profile image

Deepak L. Bhatt

Bristol-Myers Squibb

Chief Medical Officer since 2024

MD from Yale University; MSc in Clinical Epidemiology from the University of Pennsylvania

Bristol-Myers Squibb Foundation

Collaborator

Trials
6
Recruited
1,300+

Published Research Related to This Trial

Exercise training is now widely recommended for managing multiple sclerosis (MS), reflecting over 25 years of research supporting its benefits for individuals with the condition.
The paper highlights eight emerging research areas, such as behavior change interventions and telerehabilitation, that could enhance the effectiveness and implementation of exercise in clinical practice for MS patients.
Current perspectives on exercise training in the management of multiple sclerosis.Motl, RW., Sandroff, BM.[2021]
Exercise is an effective behavioral approach for improving function and managing symptoms in individuals with multiple sclerosis (MS), supported by literature reviews and meta-analyses.
The review emphasizes that exercise is generally safe for people with MS, with low reports of relapses and adverse events, and provides guidelines for safe exercise practices.
Benefits, safety, and prescription of exercise in persons with multiple sclerosis.Motl, RW.[2022]
The GEMS program is a randomized controlled trial designed to evaluate the feasibility and efficacy of a 4-month home-based exercise program for adults with mild-to-moderate multiple sclerosis, focusing on improving symptoms and health-related quality of life.
Participants will engage in aerobic and resistance training, supported by exercise equipment and regular communication with specialists, with the goal of informing future larger trials on the effectiveness of such interventions.
Feasibility study design and methods for Project GEMS: Guidelines for Exercise in Multiple Sclerosis.Adamson, BC., Learmonth, YC., Kinnett-Hopkins, D., et al.[2017]

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/26655434/
Feasibility study design and methods for Project GEMSThe Guidelines for Exercise in Multiple Sclerosis (GEMS) program is a randomized controlled trial (RCT) examining the feasibility and efficacy of a home-based ...
Feasibility study design and methods for Project GEMSThese guidelines specify that persons with MS should engage in a minimum of 30 min of aerobic exercise 2 days per week and resistance training exercises to ...
Physical Activity in Multiple Sclerosis (MS): A Novel ...To date, the evidence suggests that exercise intervention in MS holds anywhere from minimal to great promise depending on the outcome of interest. For some ...
Development of Evidence-Informed Physical Activity ...The resulting guidelines state that adults with MS should engage in at least 30 minutes of moderate intensity aerobic activity 2 times per week and strength ...
Lessons learned from clinical trials of exercise and ...There is evidence for beneficial effects of exercise and physical activity on immune cells and neurotrophic factors, brain structure and function, walking and ...
Exercise Training in Multiple Sclerosis: Preparing for ...Exercise training is safe and highly beneficial for people with multiple sclerosis (MS). •. Physical inactivity and sedentary behavior remain particularly ...
Safety of exercise training in multiple sclerosis - PubMed CentralIn studies that reported safety outcomes, there was no higher risk of relapse, AE, adverse effects or SAE for exercise training than the comparator.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security